Search results
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an...
KTLA-TV Los Angeles· 1 day agoLevi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE) of ...
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages bluebird bio Inc. Investors to Secure Counsel Before...
Digital Journal· 11 hours agoWHY: NEW YORK, NY - (NewMediaWire) - May 15, 2024 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio
Earnings call: Bluebird bio reports Q1 2024 results, anticipates growth By Investing.com
Investing.com· 7 days agoBluebird bio Inc. (BLUE) has announced its first-quarter 2024 financial results, highlighting the...
bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agobluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript May 9, 2024 bluebird bio, Inc....
A company insider recently sold 6,095 shares of Bluebird bio Inc [BLUE]. Should You also Consider to...
Knox Daily· 2 days agoBluebird bio Inc’s filing revealed that its President and CEO Obenshain Andrew unloaded Company’s shares for reported $9311.0 on Mar 04 ’24. In the deal ...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses...
FOX 4 Kansas City· 1 day agoThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
bluebird bio Inc (BLUE) Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Focus ...
GuruFocus.com via Yahoo Finance· 6 days agoOn May 9, 2024, bluebird bio Inc (NASDAQ:BLUE), a leader in gene therapy innovation, released its first quarter financial results through an 8-K filing.
Bluebird bio Inc: Is BLUE Stock Worth Buying? – Stocks Register
Stocks Register· 2 days agoThe trading price of Bluebird bio Inc (NASDAQ:BLUE) closed lower on Monday, May 13, closing at $1.02, -3.77% lower than its previous close. In examining ...
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
KTLA-TV Los Angeles· 3 days agoThe Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against bluebird
bluebird bio, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; May 28,...
Benzinga· 3 days agoInvestors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises bluebird bio, Inc. ("bluebird" or the